These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons. Baptista V; Varanda WA J Neurophysiol; 2005 Jul; 94(1):147-52. PubMed ID: 15744010 [TBL] [Abstract][Full Text] [Related]
25. The NMDA receptor complex: a long and winding road to therapeutics. Wood PL IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895 [TBL] [Abstract][Full Text] [Related]
26. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus. Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396 [TBL] [Abstract][Full Text] [Related]
28. Analysis of free D-serine in mammals and its biological relevance. Nishikawa T J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(29):3169-83. PubMed ID: 21992750 [TBL] [Abstract][Full Text] [Related]
29. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective. Priestley T; Marshall GR; Hill RG; Kemp JA Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395 [TBL] [Abstract][Full Text] [Related]
30. In vitro Characterization of a small molecule inhibitor of the alanine serine cysteine transporter -1 (SLC7A10). Brown JM; Hunihan L; Prack MM; Harden DG; Bronson J; Dzierba CD; Gentles RG; Hendricson A; Krause R; Macor JE; Westphal RS J Neurochem; 2014 Apr; 129(2):275-83. PubMed ID: 24266811 [TBL] [Abstract][Full Text] [Related]
32. D-Serine inhibits non-ionotropic NMDA receptor signaling. Barragan EV; Anisimova M; Vijayakumar V; Coblentz AC; Park DK; Salaka RJ; Nisan AFK; Petshow S; Dore K; Zito K; Gray JA bioRxiv; 2024 Jun; ():. PubMed ID: 38854020 [TBL] [Abstract][Full Text] [Related]
33. Differential regulation of NMDA receptors by d-serine and glycine in mammalian spinal locomotor networks. Acton D; Miles GB J Neurophysiol; 2017 May; 117(5):1877-1893. PubMed ID: 28202572 [TBL] [Abstract][Full Text] [Related]
34. Timing-dependent reduction in ethanol sedation and drinking preference by NMDA receptor co-agonist d-serine. Lockridge A; Romero G; Harrington J; Newland B; Gong Z; Cameron A; Yuan LL Alcohol; 2012 Jun; 46(4):389-400. PubMed ID: 22445805 [TBL] [Abstract][Full Text] [Related]
35. The pharmacological stimulation of NMDA receptors via co-agonist site: an fMRI study in the rat brain. Panizzutti R; Rausch M; Zurbrügg S; Baumann D; Beckmann N; Rudin M Neurosci Lett; 2005 May 20-27; 380(1-2):111-5. PubMed ID: 15854761 [TBL] [Abstract][Full Text] [Related]
37. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631 [TBL] [Abstract][Full Text] [Related]
39. D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons. Martina M; Krasteniakov NV; Bergeron R J Physiol; 2003 Apr; 548(Pt 2):411-23. PubMed ID: 12611916 [TBL] [Abstract][Full Text] [Related]